CLINICAL_TRIALS
trial_result
· 2022-03-10
Clinical Trial Update: Self-directed Titrated Transdermal Nicotine Patch Versus Standard Treatment for Smoking Cessation [Phase 4]
Summary
Phase 4 trial comparing self-directed titrated transdermal nicotine patch to standard treatment for smoking cessation has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Smoking Cessation | Phase 4 | Status: COMPLETED